News

New research reveals that semaglutide significantly improves liver health in MASH patients. A new study published in the New ...
A new study suggests that semaglutide, the active ingredient in Ozempic, may help decrease liver fat, inflammation, and ...
Discover how metabolic dysfunction-associated steatohepatitis (MASH) damages your liver, its connection to common health ...
A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...
Two patients with MASH share their paths to diagnosis, including the challenges they faced and what it took to find answers.
GLP-1 RA helped resolution of steatohepatitis without worsening fibrosis and reduced liver fibrosis without worsening ...
Fatty liver disease, also called metabolic dysfunction-associated steatohepatitis (MASH), is a condition where fat ...
A major international study has found that semaglutide, a drug already used to treat type 2 diabetes and obesity, can ...
Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...
A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic dysfunction-associated steatohepatitis (MASH). The interim results also reveal ...
Using semaglutide injections, scientists were able to reverse ... “It provides patients with additional choices when we think ...
So, there's this scientist, Arun Sanyal, M.D., who's the director of the VCU Stravitz-Sanyal Institute for Liver Disease and ...